Quality Industrial Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Quality Industrial Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $28.26M | May 8, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.31M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.18M | Mar 31, 2026 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.79M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.96M | Mar 31, 2026 |
| FY2022 | Dec 31, 2022 | $9.64M | May 8, 2023 |
| FY2020 | Dec 31, 2019 | $44.4K | Mar 29, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.44M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($523.0K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($4.23M) | Apr 28, 2025 |
| FY2022 | Dec 31, 2022 | $2.57M | May 8, 2023 |
| FY2022 | Dec 31, 2021 | ($147.3K) | May 8, 2023 |
| FY2021 | Dec 31, 2020 | ($1.95M) | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | ($2.89M) | Mar 29, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($456.8K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $698.3K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($2.77M) | Apr 28, 2025 |
| FY2022 | Dec 31, 2022 | $5.52M | May 8, 2023 |
| FY2022 | Dec 31, 2021 | ($146.2K) | May 8, 2023 |
| FY2021 | Dec 31, 2020 | ($1.95M) | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | ($49.9K) | Mar 29, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.2K | Apr 28, 2025 |
| FY2024 | Dec 31, 2023 | $1.3K | Apr 28, 2025 |
| FY2022 | Dec 31, 2021 | $68.2K | May 8, 2023 |
| FY2021 | Dec 31, 2020 | $6.0K | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | $2.9K | Mar 29, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $4.12M | Apr 13, 2023 |
| FY2022 | Dec 31, 2021 | $78.0K | Apr 13, 2023 |
| FY2021 | Dec 31, 2020 | $53.5K | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | $18.9K | Mar 29, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.59M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.15M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $2.36M | Apr 28, 2025 |
| FY2023 | Dec 31, 2022 | ($415.1K) | Apr 8, 2024 |
| FY2022 | Dec 31, 2021 | ($409.2K) | May 8, 2023 |
| FY2021 | Dec 31, 2020 | ($173.1K) | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | ($81.8K) | Mar 29, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $299.8K | Mar 31, 2026 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.62M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $18.11M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $8.84M | Apr 28, 2025 |
| FY2023 | May 31, 2023 | $1.01M | Apr 8, 2024 |
| FY2023 | Dec 31, 2022 | $1.01M | Apr 8, 2024 |
| FY2022 | Dec 31, 2021 | $226.1K | May 8, 2023 |
| FY2021 | Dec 31, 2020 | $207.1K | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | $131.6K | Mar 29, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.30M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $16.11M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $8.09M | Apr 28, 2025 |
| FY2023 | May 31, 2023 | $1.21M | Apr 8, 2024 |
| FY2023 | Dec 31, 2022 | $1.21M | Apr 8, 2024 |
| FY2022 | Dec 31, 2021 | $595.1K | May 8, 2023 |
| FY2021 | Dec 31, 2020 | $230.1K | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | $59.9K | Mar 29, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $743.5K | Apr 8, 2024 |
| FY2023 | Dec 31, 2022 | ($192.9K) | Apr 8, 2024 |
| FY2022 | Sep 30, 2022 | $4.12M | May 8, 2023 |
| FY2022 | Jun 30, 2022 | $1.60M | May 8, 2023 |
| FY2022 | Mar 31, 2022 | ($375.9K) | May 8, 2023 |
| FY2023 | Dec 31, 2021 | ($369.0K) | Apr 8, 2024 |
| FY2022 | Dec 31, 2020 | ($23.0K) | May 8, 2023 |
| FY2021 | Dec 31, 2019 | $71.7K | Mar 4, 2022 |
| FY2020 | Dec 31, 2018 | $35.2K | Mar 29, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.41M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $8.41M | Mar 31, 2026 |
| FY2024 | Mar 27, 2024 | $8.41M | Apr 28, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($22.67M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($17.23M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($16.70M) | Apr 28, 2025 |
| FY2023 | May 31, 2023 | ($12.47M) | Apr 8, 2024 |
| FY2023 | Dec 31, 2022 | ($12.47M) | Apr 8, 2024 |
| FY2022 | Dec 31, 2021 | ($12.76M) | May 8, 2023 |
| FY2021 | Dec 31, 2020 | ($7.58M) | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | ($5.63M) | Mar 29, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $426.6K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $225.6K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $2.5K | Apr 28, 2025 |
| FY2023 | May 31, 2023 | $3.1K | Apr 8, 2024 |
| FY2021 | Dec 31, 2021 | $15.7K | Mar 4, 2022 |
| FY2021 | Dec 31, 2020 | $19.6K | Mar 4, 2022 |
| FY2021 | Dec 31, 2019 | $131.6K | Mar 4, 2022 |
| FY2020 | Dec 31, 2018 | $126.9K | Mar 29, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $333.1K | Apr 8, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 8, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 28, 2025 |
| FY2022 | Dec 31, 2022 | 0 | May 8, 2023 |
| FY2022 | Dec 31, 2021 | 0 | May 8, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 179.11M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 126.64M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 127.13M | Apr 28, 2025 |
| FY2023 | May 31, 2023 | 102.88M | Apr 8, 2024 |
| FY2023 | Dec 31, 2022 | 102.88M | Apr 8, 2024 |
| FY2022 | Dec 31, 2021 | 94.74M | May 8, 2023 |
| FY2021 | Dec 31, 2020 | 104.96M | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | 104.43M | Mar 29, 2021 |